Lyman GH - Search Results

1

The road to romiplostim approval and beyond.

Lyman GH. Lyman GH. Oncology (Williston Park). 2009 Jul;23(8):709-10, 715. Oncology (Williston Park). 2009. PMID: 19711586 Free article. No abstract available.

2

How we treat febrile neutropenia in patients receiving cancer chemotherapy.

Lyman GH, Rolston KV. Lyman GH, et al. J Oncol Pract. 2010 May;6(3):149-52. doi: 10.1200/JOP.091092. J Oncol Pract. 2010. PMID: 20808559 Free PMC article.

3

Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.

Dinan MA, Mi X, Reed SD, Lyman GH, Curtis LH. Dinan MA, et al. Among authors: lyman gh. JAMA Oncol. 2015 Nov;1(8):1098-109. doi: 10.1001/jamaoncol.2015.2722. JAMA Oncol. 2015. PMID: 26313372

4

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW; American Society of Clinical Oncology. Lyman GH, et al. J Clin Oncol. 2007 Dec 1;25(34):5490-505. doi: 10.1200/JCO.2007.14.1283. Epub 2007 Oct 29. J Clin Oncol. 2007. PMID: 17968019 Review.

5

Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States.

Lyman GH, Lalla A, Barron RL, Dubois RW. Lyman GH, et al. Clin Ther. 2009 May;31(5):1092-104. doi: 10.1016/j.clinthera.2009.05.003. Clin Ther. 2009. PMID: 19539110

6

Antiemetics: american society of clinical oncology clinical practice guideline update.

Basch E, Hesketh PJ, Kris MG, Prestrud AA, Temin S, Lyman GH. Basch E, et al. Among authors: lyman gh. J Oncol Pract. 2011 Nov;7(6):395-8. doi: 10.1200/JOP.2011.000397. Epub 2011 Oct 21. J Oncol Pract. 2011. PMID: 22379425 Free PMC article.

7

Will biosimilars gain momentum?

Hirsch BR, Lyman GH. Hirsch BR, et al. Among authors: lyman gh. J Natl Compr Canc Netw. 2013 Oct 1;11(10):1291-7. doi: 10.6004/jnccn.2013.0149. J Natl Compr Canc Netw. 2013. PMID: 24142828 Review.

8

Cost-effectiveness of prophylaxis treatment strategies for febrile neutropenia in patients with recurrent ovarian cancer.

Fust K, Li X, Maschio M, Barron R, Weinstein MC, Parthan A, Walli-Attaei M, Chandler DB, Lyman GH. Fust K, et al. Among authors: lyman gh. Gynecol Oncol. 2014 Jun;133(3):446-53. doi: 10.1016/j.ygyno.2014.03.014. Epub 2014 Mar 19. Gynecol Oncol. 2014. PMID: 24657302

9

Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.

Dinan MA, Mi X, Reed SD, Hirsch BR, Lyman GH, Curtis LH. Dinan MA, et al. Among authors: lyman gh. JAMA Oncol. 2015 May;1(2):158-66. doi: 10.1001/jamaoncol.2015.43. JAMA Oncol. 2015. PMID: 26181015

10

Myeloid growth factors clinical practice guidelines in oncology.

Crawford J, Althaus B, Armitage J, Blayney DW, Cataland S, Dale DC, Demetri GD, Foran J, Heaney ML, Htoy S, Kloth DD, Lyman GH, Michaud L, Motl S, Vadhan-Raj S, Wong MK; National Comprehensive Cancer Network. Crawford J, et al. Among authors: lyman gh. J Natl Compr Canc Netw. 2005 Jul;3(4):540-55. doi: 10.6004/jnccn.2005.0030. J Natl Compr Canc Netw. 2005. PMID: 16038645 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

568 results

Search Page